2020
DOI: 10.1101/2020.07.10.197459
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Programming Multifaceted Pulmonary T-Cell Immunity by Combination Adjuvants

Abstract: Induction of protective mucosal T-cell memory remains a formidable challenge to vaccinologists. Using a novel adjuvant strategy that elicits unusually potent CD8 and CD4 T-cell responses, we have defined the tenets of vaccine-induced pulmonary T-cell immunity. An acrylic acid-based adjuvant (ADJ), in combination with TLR agonists glucopyranosyl lipid adjuvant (GLA) or CpG promoted mucosal imprinting but engaged distinct transcription programs to drive different degrees of terminal differentiation and d… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1
1

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 59 publications
(69 reference statements)
0
2
0
Order By: Relevance
“…In vaccine studies in the lung against influenza viruses, adjuvants, which are TLR agonist, induce an effective polyfunctional T cell immunity. Nevertheless, the induction of CD69 and CD103 expression was similar between different adjuvants [ 80 ]. A direct activation and differentiation of T RM cells by TLR activation could not be shown in the liver yet.…”
Section: Liver T Rm Cells—in Health Disease Anmentioning
confidence: 99%
“…In vaccine studies in the lung against influenza viruses, adjuvants, which are TLR agonist, induce an effective polyfunctional T cell immunity. Nevertheless, the induction of CD69 and CD103 expression was similar between different adjuvants [ 80 ]. A direct activation and differentiation of T RM cells by TLR activation could not be shown in the liver yet.…”
Section: Liver T Rm Cells—in Health Disease Anmentioning
confidence: 99%
“…Carbomer-based adjuvants have shown great promise in veterinary vaccines (22,23), in stimulating neutralizing antibodies against HIV and malaria antigens (24,25), and also in experimental vaccines against influenza virus in mice (26)(27)(28)(29). Combination adjuvants provide effective T cell-based immunity to influenza A virus (29), but is unknown whether vaccines formulated in ADJ can provide T-cell-based protection against systemic infections.…”
Section: Introductionmentioning
confidence: 99%